ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $458,000 | -23.3% | 35,890 | -23.8% | 0.18% | -7.2% |
| Q1 2017 | $597,000 | +15.0% | 47,092 | +19.5% | 0.19% | +56.5% |
| Q3 2016 | $519,000 | -56.3% | 39,400 | -57.9% | 0.12% | -43.1% |
| Q2 2016 | $1,188,000 | -56.8% | 93,514 | -55.1% | 0.22% | -44.9% |
| Q1 2016 | $2,749,000 | -17.3% | 208,071 | -3.7% | 0.40% | +10.6% |
| Q4 2015 | $3,323,000 | -12.9% | 216,092 | -29.8% | 0.36% | -2.7% |
| Q3 2015 | $3,815,000 | -12.2% | 307,671 | -3.1% | 0.37% | -13.2% |
| Q2 2015 | $4,343,000 | -14.5% | 317,501 | -25.2% | 0.42% | -14.9% |
| Q1 2015 | $5,079,000 | +3016.0% | 424,688 | +3225.1% | 0.50% | +3012.5% |
| Q4 2014 | $163,000 | -87.0% | 12,772 | -86.3% | 0.02% | -85.2% |
| Q3 2014 | $1,250,000 | +2.0% | 93,171 | +22.0% | 0.11% | +12.5% |
| Q2 2014 | $1,226,000 | -47.6% | 76,388 | -57.8% | 0.10% | -2.0% |
| Q2 2013 | $2,341,000 | – | 180,885 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |